China's First Vaccine Passes Animal Tests For H7N9 Bird Flu Virus
This article was originally published in PharmAsia News
China researchers say their vaccine against the H7N9 avian flu virus has passed animal tests, based on a swab taken from one of this year's early cases last April.
You may also be interested in...
Novartis has been tipped to regain dominance in AMD, but Bayer/Regeneron have also gained 12-week dosing approval.
Xellia has added a 500mg/100ml variant to its range of vancomycin ready-to-use bags in the US, while Kabi has introduced ertapenem 1g vials and struck a critical-care supply deal with Vizient.